Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemia
Erythroferrone (ERFE) is produced by erythroblasts in response to erythropoietin (EPO) and acts in the liver to prevent hepcidin stimulation by BMP6. Hepcidin suppression allows for the mobilization of iron to the bone marrow for the production of red blood cells. Aberrantly high circulating ERFE in...
Main Authors: | Arezes, J, Foy, N, McHugh, K, Quinkert, D, Benard, S, Sawant, A, Frost, J, Armitage, A, Pasricha, S, Lim, P, Tam, M, Lavallie, E, Pittman, D, Cunningham, O, Lambert, M, Murphy, J, Draper, S, Jasuja, R, Drakesmith, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
American Society of Hematology
2020
|
Registos relacionados
-
Erythroferrone inhibits the induction of hepcidin by BMP6
Por: Arezes, J, et al.
Publicado em: (2018) -
Is the Role of Hepcidin and Erythroferrone in the Pathogenesis of Beta Thalassemia the Key to Developing Novel Treatment Strategies?
Por: Tsz Yuen Au, et al.
Publicado em: (2022-09-01) -
Regulation of hepcidin by erythropoiesis: The story so far.
Por: Pasricha, S, et al.
Publicado em: (2016) -
Erythroferrone: An Erythroid Regulator of Hepcidin and Iron Metabolism
Por: Richard Coffey, et al.
Publicado em: (2018-04-01) -
Erythroferrone and hepcidin levels in children with iron deficiency anemia
Por: Ramazan Dulkadir, et al.
Publicado em: (2024-04-01)